Loading...

We've got a brand new version of Simply Wall St! Try it out

CounterPath

Nasdaq:CPAH
Snowflake Description

Overvalued with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CPAH
Nasdaq
CA$9M
Market Cap
  1. Home
  2. US
  3. Software
Company description

CounterPath Corporation designs, develops, and sells software and services that enable enterprises and telecommunication service providers to deliver unified communications services over Internet protocol based networks in North America and internationally. The last earnings update was 67 days ago. More info.


Add to Portfolio Compare Print
  • CounterPath has significant price volatility in the past 3 months.
CPAH Share Price and Events
7 Day Returns
-2.7%
NasdaqCM:CPAH
2.5%
US Software
0.7%
US Market
1 Year Returns
-50.6%
NasdaqCM:CPAH
29.9%
US Software
12.9%
US Market
CPAH Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
CounterPath (CPAH) -2.7% -9.2% -12.1% -50.6% -44.8% -86.7%
US Software 2.5% 8.7% 5.7% 29.9% 116.8% 154.6%
US Market 0.7% 4.4% 7% 12.9% 39.5% 44.7%
1 Year Return vs Industry and Market
  • CPAH underperformed the Software industry which returned 29.9% over the past year.
  • CPAH underperformed the Market in United States of America which returned 12.9% over the past year.
Price Volatility
CPAH
Industry
5yr Volatility vs Market

Value

 Is CounterPath undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for CounterPath. This is due to cash flow or dividend data being unavailable. The share price is $1.09.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for CounterPath's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are CounterPath's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqCM:CPAH PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-07-31) in USD $-0.83
TSX:PATH Share Price ** TSX (2019-11-15) in CAD CA$1.45
TSX:PATH Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.756 $1.1
United States of America Software Industry PE Ratio Median Figure of 71 Publicly-Listed Software Companies 44.43x
United States of America Market PE Ratio Median Figure of 2,924 Publicly-Listed Companies 18.25x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of CounterPath.

NasdaqCM:CPAH PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSX:PATH Share Price ÷ EPS (both in USD)

= 1.1 ÷ -0.83

-1.32x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • CounterPath is loss making, we can't compare its value to the US Software industry average.
  • CounterPath is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does CounterPath's expected growth come at a high price?
Raw Data
NasdaqCM:CPAH PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.32x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Software Industry PEG Ratio Median Figure of 59 Publicly-Listed Software Companies 2.58x
United States of America Market PEG Ratio Median Figure of 2,031 Publicly-Listed Companies 1.46x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for CounterPath, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on CounterPath's assets?
Raw Data
NasdaqCM:CPAH PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-07-31) in USD $0.45
TSX:PATH Share Price * TSX (2019-11-15) in CAD CA$1.45
TSX:PATH Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.756 $1.1
United States of America Software Industry PB Ratio Median Figure of 214 Publicly-Listed Software Companies 5.84x
United States of America Market PB Ratio Median Figure of 5,081 Publicly-Listed Companies 1.74x
NasdaqCM:CPAH PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSX:PATH Share Price ÷ Book Value per Share (both in USD)

= 1.1 ÷ 0.45

2.44x

* Primary Listing of CounterPath.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • CounterPath is good value based on assets compared to the US Software industry average.
X
Value checks
We assess CounterPath's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Software industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Software industry average (and greater than 0)? (1 check)
  5. CounterPath has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is CounterPath expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CounterPath has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
14.8%
Expected Software industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is CounterPath expected to grow at an attractive rate?
  • Unable to compare CounterPath's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare CounterPath's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare CounterPath's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NasdaqCM:CPAH Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Software Industry Earnings Growth Rate Market Cap Weighted Average 14.8%
United States of America Software Industry Revenue Growth Rate Market Cap Weighted Average 11.9%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14.4%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqCM:CPAH Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqCM:CPAH Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
NasdaqCM:CPAH Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-07-31 10 -4 -5
2019-04-30 11 -3 -5
2019-01-31 11 -3 -6
2018-10-31 11 -2 -5
2018-07-31 12 -2 -3
2018-04-30 12 -2 -3
2018-01-31 12 -2 -3
2017-10-31 11 -2 -3
2017-07-31 11 -1 -3
2017-04-30 11 -1 -2
2017-01-31 11 -1 -3
2016-10-31 11 -1 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if CounterPath is high growth as no earnings estimate data is available.
  • Unable to determine if CounterPath is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqCM:CPAH Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from CounterPath Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:CPAH Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
NasdaqCM:CPAH Past Financials Data
Date (Data in USD Millions) EPS *
2019-07-31 -0.83
2019-04-30 -0.84
2019-01-31 -0.94
2018-10-31 -0.91
2018-07-31 -0.54
2018-04-30 -0.59
2018-01-31 -0.50
2017-10-31 -0.50
2017-07-31 -0.67
2017-04-30 -0.52
2017-01-31 -0.57
2016-10-31 -0.48

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if CounterPath will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of CPAH’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. CounterPath's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Software companies here
  3. CounterPath's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess CounterPath's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
CounterPath has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has CounterPath performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare CounterPath's growth in the last year to its industry (Software).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • CounterPath does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare CounterPath's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare CounterPath's 1-year growth to the US Software industry average as it is not currently profitable.
Earnings and Revenue History
CounterPath's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from CounterPath Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:CPAH Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-07-31 10.45 -4.93 7.79 5.28
2019-04-30 10.76 -5.01 8.16 5.55
2019-01-31 10.69 -5.58 8.67 5.62
2018-10-31 11.19 -5.30 8.58 5.61
2018-07-31 12.16 -3.08 8.13 5.55
2018-04-30 12.38 -3.22 8.04 5.51
2018-01-31 11.96 -2.62 7.32 5.37
2017-10-31 11.43 -2.52 6.90 5.23
2017-07-31 10.77 -3.25 7.02 5.05
2017-04-30 10.69 -2.46 7.07 4.84
2017-01-31 11.37 -2.61 7.22 4.74
2016-10-31 11.47 -2.17 7.39 4.65
2016-07-31 11.75 -1.94 7.33 4.61
2016-04-30 11.08 -2.69 7.52 4.74
2016-01-31 11.14 -3.11 7.87 4.91
2015-10-31 11.51 -3.38 8.62 5.12
2015-07-31 11.33 -4.49 9.24 5.46
2015-04-30 12.00 -4.44 9.46 5.67
2015-01-31 12.57 -3.38 9.37 5.71
2014-10-31 12.15 -5.08 9.28 5.72
2014-07-31 11.85 -5.75 9.26 5.59
2014-04-30 11.68 -5.91 9.15 5.51
2014-01-31 12.03 -5.46 9.19 5.49
2013-10-31 12.70 -3.41 8.93 5.60
2013-07-31 13.71 -1.62 8.71 5.56
2013-04-30 15.24 0.47 8.92 5.50
2013-01-31 15.58 -0.88 8.89 5.54

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if CounterPath has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if CounterPath has efficiently used its assets last year compared to the US Software industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if CounterPath improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess CounterPath's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Software industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
CounterPath has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is CounterPath's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up CounterPath's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • CounterPath's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • CounterPath's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of CounterPath's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from CounterPath Company Filings, last reported 3 months ago.

NasdaqCM:CPAH Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-07-31 2.67 3.00 1.22
2019-04-30 3.23 3.00 1.86
2019-01-31 4.35 2.00 1.74
2018-10-31 5.34 1.00 1.85
2018-07-31 7.43 0.00 1.88
2018-04-30 8.24 0.00 2.35
2018-01-31 10.20 0.00 3.05
2017-10-31 8.56 0.00 1.68
2017-07-31 8.68 0.00 2.53
2017-04-30 7.18 0.00 2.07
2017-01-31 8.57 0.00 2.52
2016-10-31 7.88 0.00 1.92
2016-07-31 8.57 0.00 2.16
2016-04-30 9.10 0.00 2.16
2016-01-31 8.46 0.00 2.61
2015-10-31 9.37 0.00 3.11
2015-07-31 8.19 0.00 2.21
2015-04-30 9.92 0.00 2.85
2015-01-31 10.19 0.00 3.70
2014-10-31 12.26 0.00 5.06
2014-07-31 14.10 0.00 6.85
2014-04-30 15.08 0.00 7.17
2014-01-31 15.34 0.00 8.14
2013-10-31 17.85 0.00 9.42
2013-07-31 19.84 0.00 11.25
2013-04-30 20.93 0.00 11.23
2013-01-31 20.89 0.00 12.83
  • CounterPath's level of debt (112.3%) compared to net worth is high (greater than 40%).
  • Unable to establish if CounterPath's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • CounterPath has less than a year of cash runway based on current free cash flow.
  • CounterPath has less than a year of cash runway if free cash flow continues to grow at historical rates of 40.2% each year.
X
Financial health checks
We assess CounterPath's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. CounterPath has a total score of 0/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is CounterPath's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from CounterPath dividends.
If you bought $2,000 of CounterPath shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate CounterPath's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate CounterPath's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqCM:CPAH Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Software Industry Average Dividend Yield Market Cap Weighted Average of 21 Stocks 1.4%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1955 Stocks 2.3%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqCM:CPAH Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as CounterPath has not reported any payouts.
  • Unable to verify if CounterPath's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of CounterPath's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as CounterPath has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess CounterPath's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can CounterPath afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. CounterPath has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of CounterPath's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
David Karp
COMPENSATION $376,690
AGE 54
TENURE AS CEO 1.2 years
CEO Bio

Mr. David L. Karp, CFA, MBA, P.Eng. has been President and Chief Executive Officer at CounterPath Corporation since September 19, 2019. Mr. Karp served as an Interim Chief Executive Officer of CounterPath Corporation since September 18, 2018 until September 19, 2019. Mr. Karp served as the Chief Financial Officer of CounterPath Corporation since September 7, 2006 until September 19, 2019 and also served as Corporate Secretary and Treasurer since November 3, 2006 until September 19, 2019. Mr. Karp served as Chief Financial Officer of CounterPath Solutions Inc. since September 07, 2006 and also serves as its Secretary and Treasurer. He served as the Chief Financial Officer and Director of Finance at Neuro Discovery Inc. from February 2002 to May 2004. Prior to Neuro Discovery, he served as Vice President of Investment and Corporate Banking of BMO Capital Markets, from 1997 to 2001. Prior to BMO Capital Markets, he served as an Executive Assistant to Chief Executive Officer of Repap Enterprises. He served as Chief Financial Officer of Allon Therapeutics, Inc. Mr. Karp is a corporate finance professional with over 20 years of financial and operating experience in a variety of industries. He served as Chief Financial Officer of Chemokine Therapeutics Corp., from May 2004 to August 2006, its Director of Finance since June 2004, Secretary since January 2005 and also served its Principal Accounting Officer. He joined Chemokine Therapeutics Corp. in June 2004 and was responsible for treasury and U.S. GAAP reporting, as well as the implementation of internal controls. He served as a Director of Electronic Cigarettes International Group, Ltd. since August 18, 2014 until March 16, 2017. He served as a Director of CounterPath Solutions Inc. since September 7, 2006 until June 1, 2007. He is a Chartered Financial Analyst and a Professional Engineer. Mr. Karp holds a Bachelor of Science degree in Mechanical Engineering from the University of Waterloo and a Masters in Business Administration from the Ivey School of Business at the University of Western Ontario.

CEO Compensation
  • David's compensation has increased whilst company is loss making.
  • David's remuneration is about average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the CounterPath management team in years:

0.2
Average Tenure
49
Average Age
  • The average tenure for the CounterPath management team is less than 2 years, this suggests a new team.
Management Team

David Karp

TITLE
President & CEO
COMPENSATION
$377K
AGE
54
TENURE
1.2 yrs

Todd Carothers

TITLE
Chief Revenue Officer
COMPENSATION
$655K
AGE
49
TENURE
0.2 yrs

Karen Luk

TITLE
Vice President of Finance
AGE
37
TENURE
0.2 yrs

Michael Doyle

TITLE
Vice President of Technology

Steve Hards

TITLE
Vice President of Investor Relations

Nemer Abourizk

TITLE
General Counsel

John Wigboldus

TITLE
Senior Vice President of Sales

Hanna Miller

TITLE
Vice President of Marketing
TENURE
0.2 yrs

Steve Kinsey

TITLE
Senior Consultant & Member of Advisory Board
Board of Directors Tenure

Average tenure and age of the CounterPath board of directors in years:

14.3
Average Tenure
62
Average Age
  • The average tenure for the CounterPath board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Terry Matthews

TITLE
Independent Chairman of the Board
COMPENSATION
$44K
AGE
76

Owen Matthews

TITLE
Independent Vice Chairman of the Board
COMPENSATION
$36K
AGE
47

Bruce Joyce

TITLE
Independent Director
COMPENSATION
$38K
AGE
71
TENURE
6.2 yrs

Steve Kinsey

TITLE
Senior Consultant & Member of Advisory Board

Larry Timlick

TITLE
Independent Director
COMPENSATION
$38K
AGE
62
TENURE
14.4 yrs

Chris Cooper

TITLE
Independent Director
COMPENSATION
$38K
AGE
49
TENURE
14.3 yrs

Alan Duric

TITLE
Member of Advisory Board

Stephen Cho

TITLE
Member of Advisory Board

Robert Sparks

TITLE
Member of Advisory Board

Rohan Mahy

TITLE
Member of Advisory Board
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess CounterPath's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. CounterPath has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

CounterPath Corporation designs, develops, and sells software and services that enable enterprises and telecommunication service providers to deliver unified communications services over Internet protocol based networks in North America and internationally. Its products include Bria softphone suite, which enables consumers and business users to make voice over Internet protocol (VoIP) audio and video calls, send instant messages, manage their presence, share their screen, and collaborate with other users using desktop computers and laptops, smartphones, and tablets; and X-Lite, a standards-based VoIP softphone application that runs on desktop computers. The company also offers software development kits that deliver voice, video, and messaging capabilities for desktop, tablet, and mobile devices; Stretto Platform, a carrier-grade software platform for enterprises and service providers; Bria Teams, which delivers centralized provisioning, messaging, and screen sharing from the cloud; and Brio Stretto for enterprises, operators, and telecommunication channel partners to leverage the Stretto Platform to procure, distribute, provide, and manage Bria Stretto clients from the cloud, as well as to offer hosted messaging and collaboration solutions. In addition, it provides subscription, support, and maintenance services; and professional and other services, such as product configuration and customization, implementation, engineering, and training. The company sells its products and services through its own and third-party online stores; and directly using its in-house sales team, as well as through its channel partners. It serves small, medium, and large sized businesses; telecommunications service providers and Internet telephony service providers; original equipment manufacturers, value added distributors, and value added resellers serving the telecommunication market; and end users. CounterPath Corporation was founded in 2002 and is headquartered in Vancouver, Canada.

Details
Name: CounterPath Corporation
CPAH
Exchange: NasdaqCM
Founded: 2002
CA$6,529,082
5,956,099
Website: http://www.counterpath.com
Address: CounterPath Corporation
One Bentall Centre,
Suite 300,
Vancouver,
British Columbia, V7X 1M3,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSX PATH Common Shares The Toronto Stock Exchange CA CAD 21. Feb 2006
NasdaqCM CPAH Common Shares Nasdaq Capital Market US USD 21. Feb 2006
Number of employees
Current staff
Staff numbers
91
CounterPath employees.
Industry
Application Software
Software
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/11/18 00:12
End of day share price update: 2019/11/15 00:00
Last estimates confirmation: 2017/07/13
Last earnings filing: 2019/09/12
Last earnings reported: 2019/07/31
Last annual earnings reported: 2019/04/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.